PTSD

In a first of its kind study, MDMA-assisted therapy successfully supported patients with PTSD.

Here are 5 processes to provide focus and empowerment for patients with PTSD.

From a groundbreaking new launch for PTSD in the United States to connections between antidepressant treatment and metabolic syndrome, here are highlights from the week in Psychiatric Times.

What is new in research on posttraumatic stress disorder?

The device is now available at 2 US clinics, with training and installation currently underway at several other locations.

Here are some updates from the world of psychiatry throughout the month of December.

Initial data from phase 2 safety profile for psilocybin in the treatment of PTSD indicates the treatment is well-tolerated.

MAPS has submitted an NDA for MDMA-assisted therapy for patients with posttraumatic stress disorder.

What is new in research on psychedelics?

The experts weighed in on a wide variety of psychiatric issues for the October 2023 issue of Psychiatric Times.

From long-acting injectable antipsychotics for managing schizophrenia to mental health responses to the recent conflict in Israel, here are highlights from the week in Psychiatric Times.

Concurrent treatments targeting eating disorders and PTSD are needed to help these patients with complex conditions.

Residues of past traumatic events can deeply impact our present experiences and our functioning in ways that we are not aware of consciously. We must process and let go of these experiences in order to heal.

Climate change plays a pivotal role in the recent surge of wildfires, and their impact on mental health. How can you, as a clinician, help those impacted by these disasters, specifically children and adolescents?

New data from the Suicide and Trauma Reduction Initiative for Veterans at Ohio State University indicates the most effective interventions to prevent suicide risk among veterans.

Psychiatry will be needed to help heal the mental wounds in the Mideast.

Here are some updates from the world of psychiatry throughout the month of September.

The ongoing clinical trial is also studying the drug’s efficacy in the treatment of MDD.

"For months she has dreamed in red..."

“Our findings might inform PTSD pathology, treatment plans, and future disaster-response strategies.”

Never forget.

"Eyes locked on the flat-lined monitor, she hears the last drop gurgle, the team quiet and calm in a lake of blood."

From noninvasive brain stimulation techniques for catatonia to the concurrent treatment of eating disorders and PTSD, here are highlights from the week in Psychiatric Times.

Research shows an undeniable connection between PTSD and eating disorders.

In honor of Memorial Day...

Experts discuss findings from a new trial exploring affect-focused psychotherapies for LGBTQ+ patients with PTSD at the 2023 APA Annual Meeting.

Learn more about women’s issues, suicide, and PTSD in the military.

The second of a phase 3 study examining MDMA-AT just completed its final participant visit.

Poetic musings on posttraumatic growth...

Working with homeless patients can be exceedingly rewarding.